| Table of Contents, Volume 178, Number 4, December 2018 |
|
|
|
|
|
|
|
|
|
| Publication schedule for 2018 |
|
|
|
|
|
|
|
|
|
| PHACE syndrome: Infantile hemangiomas associated with multiple congenital anomalies: Clues to the cause |
|
|
|
|
|
|
|
|
|
| Nablus syndrome: Easy to diagnose yet difficult to solve |
|
|
|
|
|
|
|
|
|
| Clinical and genetic heterogeneity in Dubowitz syndrome: Implications for diagnosis, management and further research |
|
|
|
|
|
|
|
|
|
| The unsolved rare genetic disease atlas? An analysis of the unexplained phenotypic descriptions in OMIM® |
|
|
|
|
|
|
|
|
|
| Unsolved recognizable patterns of human malformation: Challenges and opportunities |
|
|
|
|
|
|
|
|
|
| Rhombencephalosynapsis: Fused cerebellum, confused geneticists |
|
|
|
|
|
|
|
|
|
| An update on oculocerebrocutaneous (Delleman-Oorthuys) syndrome |
|
|
|
|
|
|
|
|
|
| Hallermann-Streiff syndrome: A missing molecular link for a highly recognizable syndrome |
|
|
|
|
|
|
|
|
|
| Cover Image, Volume 178, Number 4, December 2018 |
|
|
|
|
|
|
|
|
|
| The etiology of VACTERL association: Current knowledge and hypotheses |
|
|
|
|
|
|
|
|
|
| Aicardi syndrome, an unsolved mystery: Review of diagnostic features, previous attempts, and future opportunities for genetic examination |
|
|
|
|
|
|
|
|
|
| Table of Contents, Volume 178, Number 3, September 2018 |
|
|
|
|
|
|
|
|
|
| Publication schedule for 2018 |
|
|
|
|
|
|
|
|
|
| Cover Image, Volume 178, Number 3, September 2018 |
|
|
|
|
|
|
|
|
|
| Tuberous sclerosis complex |
|
|
|
|
|
|
|
|
|
| mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex |
|
|
|
|
|
|
|
|
|
| Renal manifestation of tuberous sclerosis complex |
|
|
|
|
|
|
|
|
|
| Minimal mosaicism, maximal phenotype: Discordance between clinical and molecular findings in two patients with tuberous sclerosis |
|
|
|
|
|
|
|
|
|
| Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex |
|
|
|
|
|
|
|
|
|
| Genetics, genomics, and genotype–phenotype correlations of TSC: Insights for clinical practice |
|
|
|
|
|
|
|
|
|
| Current concepts on epilepsy management in tuberous sclerosis complex |
|
|
|
|
|
|
|
|
|
| The cutaneous manifestations of tuberous sclerosis complex |
|
|
|
|
|
|
|
|
|
| Neurocutaneous disorders |
|
|
|
|
|
|
|
|
|
| Central nervous system manifestations of tuberous sclerosis complex |
|
|
|
|
|
|
|
|
|
| Less common manifestations in TSC |
|
|
|
|
|
|
|
|
|
| A clinical update on tuberous sclerosis complex‐associated neuropsychiatric disorders (TAND) |
|
|
|
|
|
|
|
|
|
| Pulmonary manifestations in tuberous sclerosis complex |
|
|
|
|
|
|
|
|
|
| Neuropathology of holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Challenging issues arising in counseling families experiencing holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Table of Contents, Volume 178, Number 2, June 2018 |
|
|
|
|
|
|
|
|
|
| Holoprosencephaly from conception to adulthood |
|
|
|
|
|
|
|
|
|
| Publication schedule for 2018 |
|
|
|
|
|
|
|
|
|
| Holoprosencephaly flashcards: An updated summary for the clinician |
|
|
|
|
|
|
|
|
|
| Cytogenetics and holoprosencephaly: A chromosomal microarray study of 222 individuals with holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Introduction |
|
|
|
|
|
|
|
|
|
| Cover Image, Volume 178, Number 2, June 2018 |
|
|
|
|
|
|
|
|
|
| Further evidence for complex inheritance of holoprosencephaly: Lessons learned from pre‐ and postnatal diagnostic testing in Germany |
|
|
|
|
|
|
|
|
|
| Recent advances in understanding inheritance of holoprosencephaly |
|
|
|
|
|
✓ |
|
|
largest European HPE cohort |
| Syndromes associated with holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Prenatal diagnosis of holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Holoprosencephaly in the genomics era |
|
|
|
|
|
|
|
|
|
| Molecular testing in holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Nongenetic risk factors for holoprosencephaly: An updated review of the epidemiologic literature |
|
|
|
|
|
|
|
|
|
| Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Modeling the complex etiology of holoprosencephaly in mice |
|
|
|
|
|
|
|
|
|
| Holoprosencephaly: A clinical genomics perspective |
|
|
|
|
|
|
|
|
|
| Functions of TGIF homeodomain proteins and their roles in normal brain development and holoprosencephaly |
|
|
|
|
|
|
|
|
|
| Publication schedule for 2018 |
|
|
|
|
|
|
|
|
|
| Table of Contents, Volume 178C, Number 1, March 2018 |
|
|
|
|
|
|
|
|
|
| Cover Image, Volume 178C, Number 1, March 2018 |
|
|
|
|
|
|
|
|
|
| Genetic counselors as social and behavioral scientists in the era of precision medicine |
|
|
|
|
|
|
|
|
|
| Genetic counseling in industry settings: Opportunities in the era of precision health |
|
|
|
|
|
|
|
|
|
| Genetic counseling among minority populations in the era of precision medicine |
|
|
|
|
|
|
|
|
|
| Clinical genetic counselors: An asset in the era of precision medicine |
|
|
|
|
|
|
|
|
|
| Genetic counseling globally: Where are we now? |
|
|
|
|
|
|
|
|
|
| Genetic counselors on the frontline of precision health |
|
|
|
|
|
|
|
|
|
| Analysis of state laws on informed consent for clinical genetic testing in the era of genomic sequencing |
|
|
|
|
|
|
|
|
|
| The dawn of consumer‐directed testing |
|
|
|
|
|
|
|
|
|
| Genetic counseling: Growth of the profession and the professional |
|
|
|
|
|
|
|
|
|
| Genetic counselor training for the next generation: Where do we go from here? |
|
|
|
|
|
|
|
|
|
| Engaging populations underrepresented in research through novel approaches to consent |
|
|
|
|
|
|
|
|
|
| The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine |
|
|
|
|
|
|
|
|
|
| The future is now: Technology's impact on the practice of genetic counseling |
|
|
|
|
|
|
|
|
|